Global and China Blood Coagulants Market 2021 by Manufacturers, Type and Application, Forecast to 2026
Global and China Blood Coagulants Market 2021 by Manufacturers, Type and Application, Forecast to 2026
The report classifies the business vertical into various segments based on components, voltage, end-user scope, and regional division. A thorough analysis of each segment with respect to their market share, growth rate, and revenue contribution forms a major part of the study.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Market Overview
The global Blood Coagulants market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.2% in the forecast period of 2020 to 2025 and will expected to reach USD 494.7 million by 2025, from USD 388.3 million .
The Blood Coagulants market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Blood Coagulants market is split by Type and Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Breakdown by Type, Blood Coagulants market has been segmented into Recombinant coagulation factor, Plasma coagulation factor, etc.
Breakdown by Application, Blood Coagulants has been segmented into Hospital, Pharmacy, Other, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Blood Coagulants market presented in the report. This section sheds light on the sales growth of different regional and country-level Blood Coagulants markets. For the historical and forecast period 2016 to 2026, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Blood Coagulants market.
For China, this report analyses the China market by players, Type and Application, For the period 2016-2026.
Competitive Landscape and Blood Coagulants Market Share Analysis
Blood Coagulants competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Blood Coagulants sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2016-2021, this study provides the Blood Coagulants sales, revenue and market share for each player covered in this report.
The major players covered in Blood Coagulants are: Pfizer, Takeda, Bayer, CSL, Novo Nordisk, Octapharma, SOBI, etc. Among other players domestic and global, Blood Coagulants market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The key market players for global Blood Coagulants market are listed below:
Pfizer
Takeda
Bayer
CSL
Novo Nordisk
Octapharma
SOBI
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa)
Market segment by Type, covers:
Recombinant coagulation factor
Plasma coagulation factor
Market segment by Application, can be divided into
Hospital
Pharmacy
Other
1 Market Overview
1.1 Blood Coagulants Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Blood Coagulants Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Recombinant coagulation factor
1.2.3 Plasma coagulation factor
1.3 Market Analysis by Application
1.3.1 Overview: Global Blood Coagulants Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Blood Coagulants Market Size and Forecast (2016-2026)
1.4.1 Global Blood Coagulants Revenue and Forecast (2016-2026)
1.4.2 Global Blood Coagulants Sales and Forecast (2016-2026)
1.5 Global Blood Coagulants Market Size Overview by Geography (2016-2021)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Blood Coagulants Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)
2.2 Takeda
2.2.1 Takeda Details
2.2.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Takeda SWOT Analysis
2.2.4 Takeda Product and Services
2.2.5 Takeda Blood Coagulants Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Bayer SWOT Analysis
2.3.4 Bayer Product and Services
2.3.5 Bayer Blood Coagulants Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)
2.4 CSL
2.4.1 CSL Details
2.4.2 CSL Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 CSL SWOT Analysis
2.4.4 CSL Product and Services
2.4.5 CSL Blood Coagulants Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)
2.5 Novo Nordisk
2.5.1 Novo Nordisk Details
2.5.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Novo Nordisk SWOT Analysis
2.5.4 Novo Nordisk Product and Services
2.5.5 Novo Nordisk Blood Coagulants Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)
2.6 Octapharma
2.6.1 Octapharma Details
2.6.2 Octapharma Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Octapharma SWOT Analysis
2.6.4 Octapharma Product and Services
2.6.5 Octapharma Blood Coagulants Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)
2.7 SOBI
2.7.1 SOBI Details
2.7.2 SOBI Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 SOBI SWOT Analysis
2.7.4 SOBI Product and Services
2.7.5 SOBI Blood Coagulants Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)
3 Global Blood Coagulants Market, Company Landscape
3.1 Company Market Share Analysis: Global
3.1.1 Global Blood Coagulants Sales and Market Share by Manufacturer (2019-2020)
3.1.2 Global Blood Coagulants Revenue and Market Share by Manufacturer (2019-2020)
3.2 Company Market Share Analysis: China
3.2.1 Key Players Blood Coagulants Sales in China (2019-2020)
3.2.2 China Blood Coagulants Revenue Market Share by Manufacturer (2019-2020)
3.3 Market Concentration Rate
3.3.1 Top 3 Blood Coagulants Manufacturer Market Share
3.3.2 Top 6 Blood Coagulants Manufacturer Market Share
4 Market Size by Geography
4.1 Global Blood Coagulants Market Size by Geography (2016-2021)
4.1.1 Global Blood Coagulants Sales by Geography (2016-2021)
4.1.2 Global Blood Coagulants Revenue by Regions (2016-2021)
4.2 Global Blood Coagulants Market Size and Forecast by Regions (2020-2025)
4.2.1 Global Blood Coagulants Sales and Forecast by Regions (2020-2025)
4.2.2 Global Blood Coagulants Revenue and Forecast by Regions (2020-2025)
4.3 North America Blood Coagulants Market Size and Forecast (2016-2026)
4.4 Europe Blood Coagulants Market Size and Forecast (2016-2026)
4.5 Asia-Pacific Blood Coagulants Market Size and Forecast (2016-2026)
4.6 South America Blood Coagulants Market Size and Forecast (2016-2026)
4.7 Middle East and Africa Blood Coagulants Market Size and Forecast (2016-2026)
5 North America by Country
5.1 North America Blood Coagulants Market Size by Country (2016-2021)
5.1.1 North America Blood Coagulants Sales and Market Share by Country (2016-2021)
5.1.2 North America Blood Coagulants Revenue and Market Share by Country (2016-2021)
5.2 North America Blood Coagulants Market Size and Forecast by Country (2020-2025)
5.2.1 North America Blood Coagulants Sales and Forecast by Country (2020-2025)
5.2.2 North America Blood Coagulants Revenue and Forecast by Country (2020-2025)
5.3 United States Blood Coagulants Market Size and Forecast (2016-2026)
5.4 Canada Blood Coagulants Market Size and Forecast (2016-2026)
5.5 Mexico Blood Coagulants Market Size and Forecast (2016-2026)
6 Europe by Country
6.1 Europe Blood Coagulants Market Size by Country (2016-2021)
6.1.1 Europe Blood Coagulants Sales by Country (2016-2021)
6.1.2 Europe Blood Coagulants Revenue by Country (2016-2021)
6.2 Europe Blood Coagulants Market Size and Forecast by Country (2020-2025)
6.2.1 Europe Blood Coagulants Sales and Forecast by Country (2020-2025)
6.2.2 Europe Blood Coagulants Revenue and Forecast by Country (2020-2025)
6.3 Germany Blood Coagulants Market Size and Forecast (2016-2026)
6.4 United Kingdom Blood Coagulants Market Size and Forecast (2016-2026)
6.5 France Blood Coagulants Market Size and Forecast (2016-2026)
6.6 Russia Blood Coagulants Market Size and Forecast (2016-2026)
6.7 Italy Blood Coagulants Market Size and Forecast (2016-2026)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Blood Coagulants Market Size by Region (2016-2021)
7.1.1 Asia-Pacific Blood Coagulants Sales by Region (2016-2021)
7.1.2 Asia-Pacific Blood Coagulants Revenue by Region (2016-2021)
7.2 Asia-Pacific Blood Coagulants Market Size and Forecast by Region (2020-2025)
7.2.1 Asia-Pacific Blood Coagulants Sales and Forecast by Region (2020-2025)
7.2.2 Asia-Pacific Blood Coagulants Revenue and Forecast by Region (2020-2025)
7.3 China Blood Coagulants Market Size and Forecast (2016-2026)
7.4 Japan Blood Coagulants Market Size and Forecast (2016-2026)
7.5 Korea Blood Coagulants Market Size and Forecast (2016-2026)
7.6 India Blood Coagulants Market Size and Forecast (2016-2026)
7.7 Southeast Asia Blood Coagulants Market Size and Forecast (2016-2026)
7.8 Australia Blood Coagulants Market Size and Forecast (2016-2026)
8 South America by Country
8.1 South America Blood Coagulants Market Size by Country (2016-2021)
8.1.1 South America Blood Coagulants Sales by Country (2016-2021)
8.1.2 South America Blood Coagulants Revenue by Country (2016-2021)
8.2 South America Blood Coagulants Market Size and Forecast by Country (2020-2025)
8.2.1 South America Blood Coagulants Sales and Forecast by Country (2020-2025)
8.2.2 South America Blood Coagulants Revenue and Forecast by Country (2020-2025)
8.3 Brazil Blood Coagulants Market Size and Forecast (2016-2026)
8.4 Argentina Blood Coagulants Market Size and Forecast (2016-2026)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Blood Coagulants Market Size by Country (2016-2021)
9.1.1 Middle East & Africa Blood Coagulants Sales by Country (2016-2021)
9.1.2 Middle East & Africa Blood Coagulants Revenue by Country (2016-2021)
9.2 Middle East & Africa Blood Coagulants Market Size and Forecast by Country (2020-2025)
9.2.1 Middle East & Africa Blood Coagulants Sales and Forecast by Country (2020-2025)
9.2.2 Middle East & Africa Blood Coagulants Revenue and Forecast by Country (2020-2025)
9.3 Saudi Arabia Blood Coagulants Market Size and Forecast (2016-2026)
9.4 Turkey Blood Coagulants Market Size and Forecast (2016-2026)
9.5 Egypt Blood Coagulants Market Size and Forecast (2016-2026)
9.6 South Africa Blood Coagulants Market Size and Forecast (2016-2026)
10 Market Segment by Type
10.1 Global Blood Coagulants Market Size by Type (2016-2021)
10.1.1 Global Blood Coagulants Sales by Type (2016-2021)
10.1.2 Global Blood Coagulants Revenue by Type (2016-2021)
10.1.3 Global Blood Coagulants Price by Type (2016-2021)
10.2 Global Blood Coagulants Market Size and Forecast by Type (2020-2025)
10.2.1 Global Blood Coagulants Sales and Forecast by Type (2020-2025)
10.2.2 Global Blood Coagulants Revenue and Forecast by Type (2020-2025)
10.2.3 Global Blood Coagulants Price and Forecast by Type (2020-2025)
10.3 China Blood Coagulants Market Size and Forecast by Type (2016-2026)
10.3.1 China Blood Coagulants Market Size by Type (2016-2021)
10.3.2 China Blood Coagulants Market Size and Forecast by Type (2020-2025)
11 Market Segment by Application
11.1 Global Blood Coagulants Market Size by Application (2016-2021)
11.1.1 Global Blood Coagulants Sales by Application (2016-2021)
11.1.2 Global Blood Coagulants Revenue by Application (2016-2021)
11.1.3 Global Blood Coagulants Price by Application (2016-2021)
11.2 Global Blood Coagulants Market Size and Forecast by Application (2020-2025)
11.2.1 Global Blood Coagulants Sales and Forecast by Application (2020-2025)
11.2.2 Global Blood Coagulants Revenue and Forecast by Application (2020-2025)
11.2.3 Global Blood Coagulants Price and Forecast by Application (2020-2025)
11.3 China Blood Coagulants Market Size and Forecast by Application (2016-2026)
11.3.1 China Blood Coagulants Market Size by Application (2016-2021)
11.3.2 China Blood Coagulants Market Size and Forecast by Application (2020-2025)
12 Sales Channel, Distributors, Costumers, and Market Dynamics
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Distributors, Traders and Dealers
12.4.1 Market Opportunities
12.4.2 Market Risk
12.4.3 Market Driving Force
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Research Methodology:
Blood Coagulants Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|